0001620463-20-000002.txt : 20200612 0001620463-20-000002.hdr.sgml : 20200612 20200612092451 ACCESSION NUMBER: 0001620463-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 EFFECTIVENESS DATE: 20200612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athira Pharma, Inc. CENTRAL INDEX KEY: 0001620463 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368812 FILM NUMBER: 20959082 BUSINESS ADDRESS: STREET 1: 4000 MASON ROAD, SUITE 300 STREET 2: BOX 352141 CITY: SEATTLE STATE: WA ZIP: 981952141 BUSINESS PHONE: 5095927191 MAIL ADDRESS: STREET 1: 4000 MASON ROAD, SUITE 300 STREET 2: BOX 352141 CITY: SEATTLE STATE: WA ZIP: 981952141 FORMER COMPANY: FORMER CONFORMED NAME: M3 Biotechnology, Inc. DATE OF NAME CHANGE: 20140924 D 1 primary_doc.xml X0708 D LIVE 0001620463 Athira Pharma, Inc. 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA WASHINGTON 981952141 5095927191 DELAWARE M3 Biotechnology, Inc. Corporation true Leen Kawas 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Executive Officer Director Promoter Joseph W. Harding 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Director John M. Fluke, Jr. 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Director Tadataka Yamada 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Director Mark Litton 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Executive Officer Glenna Mileson 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Executive Officer Christina Thomson 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Executive Officer Joseph Edelman 4000 Mason Road, Suite 300 Box 352141 Seattle WA WASHINGTON 981952141 Director Biotechnology Decline to Disclose 06b false 2020-05-29 false true true true false 0 JMP Securities 22208 None None 600 Montgomery Street Suite 1100 San Francisco CA CALIFORNIA 94111 AK ALASKA CA CALIFORNIA CO COLORADO GA GEORGIA MD MARYLAND MA MASSACHUSETTS NY NEW YORK NC NORTH CAROLINA TX TEXAS WA WASHINGTON false 90944020 89007350 1936670 In addition to the issuance of capital stock, the Issuer issued warrants to purchase capital stock, the proceeds of which, if any, will be realized at the time of exercise. false 73 3445000 true 0 Cash fees of up to $3,455,000, plus warrants to purchase shares of Series B preferred stock at the Series B purchase price. 0 false Athira Pharma, Inc. /s/ Leen Kawas Leen Kawas Chief Executive Officer 2020-06-12